EQ
Equillium Inc
NASDAQ: EQ · HEALTHCARE · BIOTECHNOLOGY
$2.08
+1.46% today
Updated 2026-04-29
Market cap
$136.57M
P/E ratio
—
P/S ratio
20.22x
EPS (TTM)
$-0.39
Dividend yield
—
52W range
$0 – $3
Volume
0.5M
Equillium Inc (EQ) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-662201.00 | $-7.53M | $-22.95M | $-24.62M | $-32.08M | $-8.73M | $-21.78M | $-19.03M | $-22.75M |
| Capital expenditures | $2199.00 | $34858.00 | $74000.00 | $202000.00 | $57000.00 | $279000.00 | $50000.00 | $85000.00 | $48000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $441914.00 | $2.25M | $3.82M | $4.41M | $4.84M | $4.00M | $3.75M | $2.32M |
| Free cash flow | $-664400.00 | $-7.56M | $-23.02M | $-24.83M | $-32.14M | $-9.01M | $-21.83M | $-19.11M | $-22.79M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $9.88M | — | — | — | $9.13M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | $21.40M | $-15.28M | $10.73M | $26.39M | — | — | — | — |